{"id":"cd25","name":"CD25 (IL-2 receptor alpha)","symbol":"IL2RA","route":"/targets/cd25/","asOf":"2026-09-10","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6008","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000134460","uniprot":"https://www.uniprot.org/uniprotkb/P01589/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P01589","chembl":"https://www.ebi.ac.uk/chembl/explore/target/CHEMBL1778","open-targets":"https://platform.opentargets.org/target/ENSG00000134460","civic":"https://civicdb.org/genes/3559/summary","oncokb":"https://www.oncokb.org/gene/IL2RA","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=IL2RA","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=IL2RA","depmap":"https://depmap.org/portal/gene/IL2RA?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000134460-IL2RA","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/3559","omim":"https://www.omim.org/entry/147730"}],"products":[{"id":"denileukin-diftitox","name":"Denileukin diftitox","status":"approved","modality":"IL-2 receptor-directed cytotoxin (fusion protein)","route":"/drugs/denileukin-diftitox/"},{"id":"tak-928","name":"TAK-928","status":"phase-3","modality":"bispecific antibody","route":"/drugs/tak-928/"}],"trials":[{"id":"nct07217301","name":"A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer","nct":"NCT07217301","phase":"3","status":"recruiting"},{"id":"nct01127451","name":"Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma","nct":"NCT01127451","phase":"2","status":"completed"},{"id":"nct00299689","name":"Phase II Trial of Ontak With Metastatic Melanoma","nct":"NCT00299689","phase":"2","status":"completed"},{"id":"nct00880360","name":"A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer","nct":"NCT00880360","phase":"2","status":"completed"}],"pathways":[],"companies":["citius-pharmaceuticals","eisai","takeda"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}